Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample

Schizophrenia Research

Volumn 66, Issue 2-3, 2004, Pages 115-124

  Kavanagh, David J ^a   Waghorn, Geoffrey ^a,b   Jenner, Linda ^c   Chant, David C ^a,b   Carr, Vaughan ^d   Evans, Mandy ^e   Herrman, Helen ^f,g   Jablensky, Assen ^h   McGrath, John J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Epidemiology; Psychosis; Schizophrenia; Substance abuse; Substance dependence

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; CAFFEINE; CANNABIS; COCAINE; DIAMORPHINE; SOLVENT; TRANQUILIZER;

ACADEMIC ACHIEVEMENT; AGE; ALCOHOL ABUSE; ARTICLE; COMORBIDITY; CORRELATION ANALYSIS; DEMOGRAPHY; MASCULINITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SUBSTANCE ABUSE;

EID: 0346786361     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00130-0     Document Type: Article

References (35)

1. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3rd ed. revised:1987;APA, Washington, DC.
2. Bartels S.J., Teague G.B., Drake R.E., Clark R.E., Bush P.W., Noordsy D.L. Substance abuse in schizophrenia: service utilization and costs. J. Nerv. Ment. Dis. 181:1993;227-232.
3. Bebbington P., Nayani T. The psychosis screening instrument questionnaire. Int. J. Methods Psychiatr. Res. 5:1995;11-19.
4. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biol. Bull. 2:1949;47-53.
5. Cantor-Graae E., Nordstrom L.G., McNeil T.F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 48:2001;69-82.
6. Castle D., Morgan V., Jablensky A. Antipsychotic use in Australia: the patients' perspective. Aust. N.Z. J. Psychiatry. 36:2002;633-641.
7. Cox D.R., Snell E.J. The Analysis of Binary Data. 3rd ed. 1989;Chapman and Hall, London.
8. Degenhardt L., Hall W., Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction. 96:2001;1603-1614.
9. Drake R.E., Brunette M.F. Complications of severe mental illness related to alcohol and other drug use disorders. Galanter M. Recent Developments in Alcoholism. 1998;285-299 Plenum, New York.
10. Drake R., Osher F., Wallach M. Alcohol use and abuse in schizophrenia: a prospective community study. J. Nerv. Ment. Dis. 177:1989;408-414.
11. Duke P.J., Pantelis C., McPhillips M.A.et al. Comorbid non-alcohol substance misuse among people with schizophrenia. Br. J. Psychiatry. 179:2001;509-513.
12. Ewing J.A. Detecting alcoholism: the CAGE questionnaire. J. Am. Med. Assoc. 252:1984;1905-1907.
13. Fowler I.L., Carr V.J., Carter N.T.et al. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 24:1998;443-455.
14. Hambrecht M., Hafner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust. N.Z. J. Psychiatry. 34:2000;468-475.
15. Jablensky A., McGrath J., Herrman H.et al. National Survey of Mental Health and Well-Being. Report 4. People Living with Psychotic Illness: An Australian Study 1997-98. 1999;Commonwealth Department of Health and Aged Care, Canberra.
16. Jablensky A., McGrath J., Herrman H.et al. Diagnostic interview for psychoses. Interview Schedule, Version 1.0, National Survey of Mental Health and Well-Being Report 4: People Living with Psychotic Illness: An Australian Study 1997-98. 1999;Commonwealth Department of Health and Aged Care, Canberra.
17. Jablensky A., McGrath J., Herrman H.et al. Psychotic disorders in urban areas: an overview of the study on low prevalence disorders. Aust. N.Z. J. Psychiatry. 34:2000;221-236.
18. Khan K.S., Chien P.F.W., Dwarakanath L.S. Logistic regression models in obstetrics and gynecology literature. Obstet. Gynecol. 93:1999;1014-1020.
19. Lenzenweger M.F., Dworkin R.H. The dimensions of schizophrenia phenomenology: not one or two, at least three, perhaps four. Br. J. Psychiatry. 168:1996;432-440.
20. Liddle P.F. The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br. J. Psychiatry. 151:1987;145-151.
21. Littrell K.H., Petty R.G., Hilligoss N.M.et al. Olanzapine treatment for patients with schizophrenia and substance abuse. J. Subst. Abuse Treat. 21(4):2001;217-221.
22. McGuffin P., Farmer A.E., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry. 48:1991;764-770.
23. Mueser K.T., Drake R.E., Ackerson T.H.et al. Antisocial personality disorder, conduct disorder and substance abuse in schizophrenia. J. Abnorm. Psychol. 106:1997;473-477.
24. Mueser K.T., Rosenberg S.D., Drake R.E.et al. Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders. J. Stud. Alcohol. 61:1999;278-284.
25. Mueser K.T., Yarnold P.R., Rosenberg S.D.et al. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr. Bull. 26:2000;179-192.
26. Patkar A.A., Alexander R.C., Lundy A., Certa K.M. Changing patterns of illicit substance use among schizophrenic patients: 1984-1996. Am. J. Addict. 8:1999;65-71.
27. Peralta V., Leon J., Cuesta M.J. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br. J. Psychiatry. 161:1992;335-343.
28. Regier D.A., Farmer M.E., Rae D.S.et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. J. Am. Med. Assoc. 264:1990;2511-2518.
29. Robins L.N., Wing J., Wittchen H.U.et al. The Composite International Diagnostic Interview. An epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry. 45:1988;1069-1077.
30. Rosenman S., Korten A., Medway J., Evans M. Characterising psychosis in the Australian National Survey of Mental Health and Well-Being study on low prevalence disorders. Aust. N.Z. J. Psychiatry. 34:2000;792-800.
31. Salyers M.P., Mueser K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr. Res. 48:2001;109-123.
32. Teeson M., Hall W., Lynskey M.et al. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Well-Being. Aust. N.Z. J. Psychiatry. 34:2000;206-213.
33. Warner L.A., Kessler R.C., Hughes M.et al. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 52:1995;219-229.
34. Wickham H., Walsh C., Asherson P.et al. Familiarity of symptom dimensions in schizophrenia. Schizophr. Res. 47:2001;223-232.
35. Wing J.K., Babor T., Brugha T.et al. SCAN: schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiatry. 47:1990;589-593.